Enovix (NASDAQ:ENVX) Releases Q3 2026 Earnings Guidance

Enovix (NASDAQ:ENVX) updated its third quarter 2026 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of -0.170–0.130 for the period, compared to the consensus earnings per share estimate of -0.150. The company issued revenue guidance of $9.0 million-$10.0 million, compared to the consensus revenue estimate of $10.3 million.

Enovix Price Performance

Shares of ENVX stock traded down $0.10 on Wednesday, hitting $4.73. 8,784,618 shares of the stock traded hands, compared to its average volume of 6,373,630. The firm has a market cap of $1.03 billion, a price-to-earnings ratio of -5.70 and a beta of 2.32. Enovix has a 52 week low of $3.67 and a 52 week high of $14.21. The firm has a 50 day simple moving average of $5.54 and a two-hundred day simple moving average of $5.92. The company has a debt-to-equity ratio of 2.14, a current ratio of 10.97 and a quick ratio of 10.65.

Enovix (NASDAQ:ENVX) last released its earnings results on Wednesday, August 12th. The company reported ($0.13) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.02. The company had revenue of $9.02 million for the quarter, compared to analysts’ expectations of $8.43 million. Enovix had a negative net margin of 499.64% and a negative return on equity of 64.28%. Enovix has set its Q3 2026 guidance at -0.170–0.130 EPS. As a group, equities research analysts predict that Enovix will post -0.79 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on ENVX shares. Weiss Ratings restated a “sell (e+)” rating on shares of Enovix in a research report on Wednesday, July 8th. Craig Hallum lowered their price target on Enovix from $10.00 to $8.00 and set a “buy” rating on the stock in a report on Thursday, May 14th. Wall Street Zen upgraded Enovix from a “strong sell” rating to a “sell” rating in a research note on Saturday, May 16th. Benchmark cut their price objective on shares of Enovix from $25.00 to $15.00 and set a “buy” rating for the company in a report on Thursday, May 14th. Finally, Oppenheimer cut their price objective on shares of Enovix from $24.00 to $21.00 and set an “outperform” rating for the company in a report on Thursday, May 14th. Six equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat, Enovix presently has an average rating of “Hold” and a consensus price target of $12.50.

Hedge Funds Weigh In On Enovix

Several institutional investors have recently added to or reduced their stakes in the company. Millennium Management LLC raised its position in shares of Enovix by 1,038.9% during the 3rd quarter. Millennium Management LLC now owns 1,476,879 shares of the company’s stock valued at $14,724,000 after buying an additional 1,347,200 shares in the last quarter. Two Sigma Investments LP grew its position in Enovix by 9,197.1% in the third quarter. Two Sigma Investments LP now owns 1,200,997 shares of the company’s stock worth $11,974,000 after acquiring an additional 1,188,079 shares in the last quarter. Barclays PLC increased its stake in Enovix by 263.1% during the fourth quarter. Barclays PLC now owns 1,551,941 shares of the company’s stock worth $11,345,000 after acquiring an additional 1,124,480 shares during the last quarter. Electron Capital Partners LLC increased its stake in Enovix by 13.8% during the third quarter. Electron Capital Partners LLC now owns 8,038,396 shares of the company’s stock worth $80,143,000 after acquiring an additional 972,103 shares during the last quarter. Finally, Fred Alger Management LLC raised its position in Enovix by 58.9% during the fourth quarter. Fred Alger Management LLC now owns 2,292,315 shares of the company’s stock valued at $16,757,000 after purchasing an additional 849,329 shares during the period. Hedge funds and other institutional investors own 50.92% of the company’s stock.

Enovix Company Profile

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.